Repligen – About the Company

Repligen Corporation (Nasdaq: RGEN) is a life sciences company focused on the development and commercialization of high-value consumable products used in the process of manufacturing biological drugs. Their bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. They are the leading manufacturer of Protein A affinity ligands, a critical component of Protein A media that is used to separate and purify monoclonal antibody therapeutics. The ATF (Alternating Tangential Flow) System and the growth factor products are used to increase product yield during the fermentation stage of biologic drug manufacturing. In addition, theu have developed and market an innovative line of “ready-to-use” chromatography columns under the OPUS® brand (Open-Platform User-Specified) that they deliver prepacked with their customers’ choice of purification media.